Search results
Hunter syndrome, or mucopolysaccharidosis type II (MPS II), is a rare genetic disorder in which large sugar molecules called glycosaminoglycans (or GAGs or mucopolysaccharides) build up in body tissues.
Jul 27, 2023 · Hunter syndrome, or mucopolysaccharidosis type II (MPS II), is a rare inherited lysosomal storage disorder. With MPS II, sugar molecules called glycosaminoglycans (GAGs) build up within the lysosomes of your child’s cells. This buildup causes damage that affects physical and mental development.
Jul 25, 2023 · Mucopolysaccharidosis Type II (Hunter syndrome) is a rare X-linked recessive disorder. It has an early age of onset with clinical symptoms involving multiple organ systems. The severity of the disease depends on the phenotype. The severe phenotype has high morbidity and mortality.
May 1, 2024 · Hunter syndrome, also called mucopolysaccharidosis type II, is an inherited genetic disorder that occurs almost exclusively in males. It results from a gene mutation that leads to the buildup...
Hunter syndrome (also called mucopolysaccharidosis, type 2 or MPS II) is a genetic condition in which the body creates too little iduronate 2-sulfatase enzyme (an enzyme that helps the body break down certain types of sugar).
Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, is a condition that affects many different parts of the body and occurs almost exclusively in men. Explore symptoms, inheritance, genetics of this condition.
Mucopolysarcharidosis type II (MPS II) is a rare, inherited disorder. MPS II is also known as Hunter syndrome. Children with this condition have an abnormal accumulation of complex sugars in their cells, which affects many systems in their bodies.
Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, is a rare inherited lysosomal storage disease in which the body is missing or does not have enough of an enzyme needed to break down long chains of sugar molecules called glycosaminoglycans (GAGs).
Nov 6, 2007 · Mucopolysaccharidosis type II (MPS II; also known as Hunter syndrome) is an X-linked multisystem disorder characterized by glycosaminoglycan (GAG) accumulation. The vast majority of affected individuals are male; on rare occasion heterozygous females manifest findings.
MPS II is a mucopolysaccharide disease known as Hunter syndrome. It takes its name from Charles Hunter, the professor of medicine in Manitoba, Canada, who first described two brothers with the disease in 1917.
